Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

HRTX

Heron Therapeutics Inc

Feb 13 • 02:22PM ET

1.16

+0.01 0.87 %

Healthcare • Biotechnology • USA • NASD

Peers: JNJ PFE ABBV MRK BMY GILD LLY AMGN VRTX REGN

| Held by: VTI IWM VXF IWN SCHA VTWO VHT IWC ITOT PRFZ

Index	RUT	P/E	-	EPS (ttm)	-0.08	Insider Own	1.03%	Shs Outstand	183.32M	Perf Week	-7.94%
Market Cap	212.70M	Forward P/E	-	EPS next Y	0.00	Insider Trans	0.00%	Shs Float	181.48M	Perf Month	-22.15%
Enterprise Value	305.51M	PEG	-	EPS next Q	-0.02	Inst Own	84.07%	Short Float	19.43%	Perf Quarter	4.50%
Income	-13.58M	P/S	1.37	EPS this Y	-11.11%	Inst Trans	3.56%	Short Ratio	20.46	Perf Half Y	-14.07%
Sales	155.10M	P/B	30.28	EPS next Y	100.00%	ROA	-5.78%	Short Interest	35.26M	Perf YTD	-10.77%
Book/sh	0.04	P/C	3.83	EPS next 5Y	-	ROE	-	52W High	2.68 -56.72%	Perf Year	-29.70%
Cash/sh	0.30	P/FCF	-	EPS past 3/5Y	65.87% 48.68%	ROIC	-8.79%	52W Low	1.00 16.01%	Perf 3Y	-55.21%
Dividend Est.	-	EV/EBITDA	68.50	Sales past 3/5Y	18.67% -0.23%	Gross Margin	73.92%	Volatility	6.54% 5.14%	Perf 5Y	-93.68%
Dividend TTM	-	EV/Sales	1.97	EPS Y/Y TTM	58.23%	Oper. Margin	1.35%	ATR (14)	0.08	Perf 10Y	-93.60%
Dividend Ex-Date	-	Quick Ratio	1.78	Sales Y/Y TTM	12.60%	Profit Margin	-8.75%	RSI (14)	35.47	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.56	EPS Q/Q	-223.97%	SMA20	-12.91%	Beta	1.27	Target Price	4.50
Payout	-	Debt/Eq	9.44	Sales Q/Q	16.47%	SMA50	-13.03%	Rel Volume	0.31	Prev Close	1.15
Employees	122	LT Debt/Eq	9.39	Earnings	Nov 04 BMO	SMA200	-24.27%	Avg Volume	1.72M	Price	1.16
IPO	Aug 26, 1987	Option/Short	Yes / Yes	EPS/Sales Surpr.	-566.67% -2.10%	Trades		Volume	408,179	Change	0.87%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-09-25	Initiated	H.C. Wainwright	Buy	$6
Jun-13-24	Initiated	Rodman & Renshaw	Buy	$7
Apr-23-24	Initiated	CapitalOne	Overweight	$6
Mar-13-24	Reiterated	Needham	Buy	$4 → $5
May-27-20	Initiated	Guggenheim	Buy	$24
Feb-20-20	Reiterated	Needham	Buy	$50 → $48
Jan-16-19	Reiterated	Needham	Buy	$66 → $64
Apr-05-18	Initiated	Evercore ISI	Outperform	$56
Mar-19-18	Reiterated	Mizuho	Buy	$28 → $35
Mar-01-18	Reiterated	Needham	Buy	$28 → $30
Jan-03-18	Initiated	Leerink Partners	Outperform	$22
Sep-27-17	Initiated	Northland Capital	Outperform	$40
Feb-27-17	Initiated	Needham	Buy	$28
Oct-26-16	Initiated	Aegis Capital	Buy
Sep-06-16	Resumed	Lake Street	Buy	$45
May-03-16	Initiated	Cantor Fitzgerald	Buy
Dec-10-15	Initiated	Lake Street	Buy	$45
Sep-23-15	Reiterated	Leerink Partners	Outperform	$38 → $57
Sep-02-15	Initiated	BofA/Merrill	Buy	$46
Aug-03-15	Reiterated	Brean Capital	Buy	$40 → $45

Show Previous Ratings

Jan-10-26 09:35AM	Heron Therapeutics sees Q4 revenue $40.5M, consensus $39.83M (TipRanks)
Jan-09-26 09:29AM	Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net Revenue; ZYNRELEF Largest Contributor to Q4 Growth (GlobeNewswire) +9.45%
Dec-04-25 08:15AM	Heron Therapeutics Announces Inclusion of APONVIE (aprepitant) Injectable Emulsion in the Newly Released Fifth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting (PONV) (GlobeNewswire)
Nov-04-25 04:06PM	Heron Therapeutics Inc (HRTX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
09:30AM	Heron Therapeutics (HRTX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
09:15AM	Loading…
09:15AM	Heron Therapeutics (HRTX) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
08:13AM	Heron Therapeutics: Q3 Earnings Snapshot (Associated Press Finance)
08:00AM	Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial Progress (GlobeNewswire)
Oct-29-25 05:58PM	Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors (GlobeNewswire)
Oct-21-25 04:20PM	Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 (GlobeNewswire) -8.46%
Aug-15-25 07:45AM	Heron Therapeutics, Inc. Adopts Tax Benefits Preservation Plan to Protect NOL Assets and Shareholder Value (PR Newswire)
Aug-09-25 03:05AM	Heron Therapeutics Inc (HRTX) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
Aug-08-25 09:30AM	Heron Therapeutics (HRTX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) -28.26%
08:55AM	Heron Therapeutics (HRTX) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
07:52AM	Heron Therapeutics: Q2 Earnings Snapshot (Associated Press Finance)
07:45AM	Loading…
07:45AM	Heron Therapeutics Announces Q2 2025 Financial Results and Highlights Commercial Progress (PR Newswire)
07:45AM	Heron Therapeutics Announces Comprehensive Capital Restructuring to Support Growth and Extend Maturity Profile (PR Newswire)
06:00AM	Heron Therapeutics Reschedules Second Quarter 2025 Earnings Release and Conference Call to Friday, August 8, 2025 (PR Newswire)
Jul-28-25 09:42PM	Heron Therapeutics to Report Second Quarter 2025 Financial Results on Monday, August 11, 2025 (PR Newswire)
Jul-07-25 08:50AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
Jul-04-25 08:50AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
May-07-25 03:38PM	Heron Therapeutics: Q1 Paints A Potentially Rosy Picture For 2025 (Seeking Alpha) -6.61%
03:04AM	Heron Therapeutics Inc (HRTX) Q1 2025 Earnings Call Highlights: Record EBITDA and Significant ... (GuruFocus.com)
May-06-25 09:30AM	Compared to Estimates, Heron Therapeutics (HRTX) Q1 Earnings: A Look at Key Metrics (Zacks) +13.62%
08:55AM	Heron Therapeutics (HRTX) Q1 Earnings and Revenues Top Estimates (Zacks)
07:53AM	Heron Therapeutics: Q1 Earnings Snapshot (Associated Press Finance)
07:45AM	Heron Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Corporate Updates (PR Newswire)
07:30AM	Heron Therapeutics Announces Settlement with Mylan Related to CINVANTI and APONVIE Patent Litigations (PR Newswire)
May-05-25 10:33AM	MTD Q1 Earnings Top Estimates, Sales Decline Y/Y, Shares Rise (Zacks) -7.79%
May-01-25 10:01AM	Akebia Therapeutics (AKBA) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
10:01AM	Loading…
Apr-29-25 10:01AM	Heron Therapeutics (HRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release (Zacks)
Apr-28-25 06:55PM	Heron Therapeutics Announces Appointment of Mark Hensley as Chief Operating Officer (PR Newswire)
Apr-24-25 08:56AM	Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Heron Therapeutics, Esperion Therapeutics, Pyxis Oncology and Plus Therapeutics (Zacks)
Apr-23-25 09:32AM	5 Small Drug Stocks to Buy as Tariff-Related Uncertainty Looms (Zacks)
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Apr-22-25 04:05PM	Heron Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, May 6, 2025 (PR Newswire) +11.40%
10:15AM	Best Momentum Stocks to Buy for April 22nd (Zacks)
09:40AM	Are Medical Stocks Lagging Encompass Health (EHC) This Year? (Zacks)
07:24AM	New Strong Buy Stocks for April 22nd (Zacks)
Mar-26-25 03:57PM	Is Heron Therapeutics, Inc. (HRTX) The Hot Biotech Stock Under $5? (InsiderMonkey)
Feb-28-25 02:08AM	Heron Therapeutics Inc (HRTX) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com) +20.49%
12:56AM	Q4 2024 Heron Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-27-25 09:30AM	Heron Therapeutics (HRTX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) +19.88%
07:54AM	Heron Therapeutics: Q4 Earnings Snapshot (Associated Press Finance)
07:45AM	Heron Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Updates (PR Newswire)
Feb-13-25 04:20PM	Heron Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results On Thursday, February 27, 2025 (PR Newswire) +7.88%
Dec-23-24 04:05PM	Heron Therapeutics Announces Corporate Headquarters Relocation to Cary, North Carolina (PR Newswire)
Dec-03-24 04:36PM	U.S. District Court Upholds Validity of CINVANTI Patents (PR Newswire) +38.98%
Nov-13-24 02:05AM	Heron Therapeutics Inc (HRTX) Q3 2024 Earnings Call Highlights (GuruFocus.com) -5.47%
Nov-12-24 10:00AM	Heron Therapeutics (HRTX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks) -30.43%
09:10AM	Heron Therapeutics (HRTX) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
08:06AM	Heron Therapeutics: Q3 Earnings Snapshot (Associated Press Finance)
07:55AM	Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance (PR Newswire)
Nov-07-24 09:15AM	Unveiling Heron Therapeutics (HRTX) Q3 Outlook: Wall Street Estimates for Key Metrics (Zacks)
Nov-04-24 05:00PM	Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors (PR Newswire)
Oct-29-24 04:05PM	Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024 (PR Newswire) -7.33%
Oct-10-24 04:08PM	Heron Therapeutics Reaffirms Availability and Ample Supply of CINVANTI, SUSTOL, and APONVIE as Alternatives During the Potential Shortage of Intravenous Fluids (PR Newswire)
Sep-25-24 08:00AM	Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application for ZYNRELEF Vial Access Needle ('VAN') (PR Newswire)
Sep-03-24 08:00AM	Heron Therapeutics Announces Appointment of Brett Fleshman as Chief Business Officer (PR Newswire) -10.36%
Aug-06-24 07:30PM	Heron Therapeutics (HRTX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) -25.09%
06:45PM	Heron Therapeutics (HRTX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
05:36PM	Heron Therapeutics: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Heron Therapeutics Announces Second Quarter 2024 Financial Results and Narrows Financial Guidance (PR Newswire)
Jul-30-24 04:05PM	Heron Therapeutics to Report Second Quarter 2024 Financial Results On Tuesday, August 6, 2024 (PR Newswire) +5.69%
Jul-15-24 08:00AM	Heron Therapeutics Announces the Inclusion of ZYNRELEF as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System (PR Newswire)
Jul-11-24 12:00PM	Heron Therapeutics (HRTX) Upgraded to Strong Buy: Here's What You Should Know (Zacks) +8.88%
Jul-02-24 08:00AM	Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF Vial Access Needle ('VAN') (PR Newswire) -21.04%
May-29-24 08:05AM	Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF Vial Access Needle ('VAN') (PR Newswire)
May-21-24 12:00PM	What Makes Heron Therapeutics (HRTX) a Strong Momentum Stock: Buy Now? (Zacks)
May-08-24 12:30PM	Heron Therapeutics, Inc. (NASDAQ:HRTX) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:10AM	Heron Therapeutics Inc (HRTX) Q1 2024 Earnings Call Transcript Highlights: Significant ... (GuruFocus.com)
May-07-24 12:54PM	HRTX Stock Earnings: Heron Therapeutics Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
09:34AM	Heron Therapeutics Inc (HRTX) Q1 2024 Earnings Overview: Surpasses Revenue Estimates (GuruFocus.com)
09:30AM	Heron Therapeutics (HRTX) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
09:05AM	Heron Therapeutics (HRTX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
08:06AM	Heron Therapeutics: Q1 Earnings Snapshot (Associated Press Finance)
08:00AM	Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates (PR Newswire)
Apr-30-24 10:01AM	Will Heron Therapeutics (HRTX) Report Negative Earnings Next Week? What You Should Know (Zacks) -7.20%
Apr-24-24 08:00AM	Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 (PR Newswire) -5.36%
Apr-11-24 04:05PM	Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City (PR Newswire) +7.69%
Mar-28-24 04:05PM	Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference (PR Newswire)
Mar-13-24 09:19AM	Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2023 Earnings Call Transcript (Insider Monkey) +27.54%
07:04AM	Q4 2023 Heron Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-12-24 06:00PM	Compared to Estimates, Heron Therapeutics (HRTX) Q4 Earnings: A Look at Key Metrics (Zacks)
05:33PM	Heron Therapeutics Inc (HRTX) Exceeds Full-Year Revenue Guidance for 2023 (GuruFocus.com)
04:34PM	Heron Therapeutics: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates (PR Newswire)
Mar-07-24 09:15AM	Curious about Heron Therapeutics (HRTX) Q4 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
Feb-28-24 08:00AM	Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024 (PR Newswire)
Feb-23-24 11:56AM	12 Best Rising Penny Stocks To Buy (Insider Monkey)
Feb-06-24 12:00PM	All You Need to Know About Heron Therapeutics (HRTX) Rating Upgrade to Strong Buy (Zacks)
Jan-25-24 06:44AM	Heron (HRTX) Gains 19% on FDA Nod for Zynrelef Label Expansion (Zacks)
Jan-24-24 01:47PM	Heron Therapeutics' Non-Opioid, Post-Operative Pain Drug Approved For Use In Additional Orthopedic, Soft Tissue Procedures - FDA Gives Nod (Benzinga) +18.86%
Jan-23-24 08:00PM	Heron Therapeutics Announces FDA Approval of ZYNRELEF Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures (PR Newswire) -5.98%
Jan-15-24 04:51PM	The 3 Most Undervalued Biotech Stocks to Buy in January (InvestorPlace)
09:55AM	Heron Therapeutics (HRTX) Just Flashed Golden Cross Signal: Do You Buy? (Zacks)
Jan-07-24 05:00PM	Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain (PR Newswire)
Dec-10-23 12:23PM	Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime master (Associated Press Finance)
Dec-06-23 11:55AM	13 Hot Penny Stocks To Buy According to Hedge Funds (Insider Monkey)
Nov-28-23 07:33PM	Penny Stock Powerhouses: 7 Picks Poised for Explosive Growth (InvestorPlace) -7.95% +7.00%

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in Cary, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Rubric Capital Management LP	10% Owner	Aug 08 '25	Buy	1.50	2,387,225	3,580,838	29,100,728	Aug 12 06:00 PM
Morgan Adam	Director	Aug 08 '25	Buy	1.50	1,766,546	2,649,819	8,753,290	Aug 12 05:02 PM

Peers: EXC AEP DUK D NRG SO PEG ED FE EIX

| Held by: IJH VTI VB VBK VXF XMMO UTES MDY XMHQ VPU

Index	-	P/E	81.62	EPS (ttm)	4.60	Insider Own	0.65%	Shs Outstand	45.69M	Perf Week	8.91%
Market Cap	17.17B	Forward P/E	17.67	EPS next Y	21.26	Insider Trans	0.00%	Shs Float	45.39M	Perf Month	0.24%
Enterprise Value	19.66B	PEG	1.04	EPS next Q	2.99	Inst Own	106.90%	Short Float	5.82%	Perf Quarter	2.23%
Income	226.00M	P/S	4.23	EPS this Y	-66.43%	Inst Trans	5.75%	Short Ratio	2.86	Perf Half Y	-1.28%
Sales	4.06B	P/B	11.69	EPS next Y	258.46%	ROA	3.49%	Short Interest	2.64M	Perf YTD	0.24%
Book/sh	32.15	P/C	34.54	EPS next 5Y	17.00%	ROE	11.72%	52W High	451.28 -16.74%	Perf Year	56.31%
Cash/sh	10.88	P/FCF	93.30	EPS past 3/5Y	- -	ROIC	5.09%	52W Low	158.08 137.68%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	8.52	Sales past 3/5Y	-22.69% -	Gross Margin	68.14%	Volatility	6.05% 5.64%	Perf 5Y	-
Dividend TTM	-	EV/Sales	4.84	EPS Y/Y TTM	-74.33%	Oper. Margin	47.49%	ATR (14)	20.52	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.72	Sales Y/Y TTM	80.20%	Profit Margin	5.57%	RSI (14)	55.56	Recom	1.29
Dividend Gr. 3/5Y	- -	Current Ratio	2.29	EPS Q/Q	34.85%	SMA20	5.64%	Beta	1.61	Target Price	466.17
Payout	0.00%	Debt/Eq	2.03	Sales Q/Q	35.08%	SMA50	2.63%	Rel Volume	0.48	Prev Close	367.81
Employees	1894	LT Debt/Eq	2.02	Earnings	Feb 26 AMC	SMA200	7.89%	Avg Volume	924.37K	Price	375.73
IPO	Jun 02, 2023	Option/Short	Yes / Yes	EPS/Sales Surpr.	33.51% 8.92%	Trades		Volume	338,961	Change	2.15%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-28-25	Initiated	Wells Fargo	Overweight	$453
Sep-22-25	Initiated	Scotiabank	Sector Perform	$418
Aug-20-25	Initiated	Melius	Buy	$427
Jun-13-25	Initiated	Raymond James	Outperform	$314
Mar-12-25	Initiated	Morgan Stanley	Overweight	$243
Feb-21-25	Initiated	Evercore ISI	Outperform
Feb-03-25	Initiated	BofA Securities	Buy	$253
Dec-04-24	Initiated	Daiwa Securities	Buy	$248
Oct-17-24	Initiated	JP Morgan	Overweight	$268
Sep-26-24	Initiated	RBC Capital Mkts	Outperform	$233
Sep-18-24	Initiated	UBS	Buy	$197
Sep-13-24	Initiated	Jefferies	Buy	$226
Sep-04-24	Initiated	Guggenheim	Buy	$169
Aug-21-24	Initiated	Barclays	Overweight	$178

Show Previous Ratings

Feb-12-26 10:54AM	Terrestrial Energy: Nuclear Disruptor Positioned for Bull Run Initiation Report (Exec Edge)
Feb-10-26 05:32PM	Local regulators deny rezoning request for Pennsylvania data center development (Reuters)
Feb-09-26 12:05PM	Wells Fargo Highlights Talen Energy (TLN) as Key Player in PJM Colocation, Resource Adequacy Debates (Insider Monkey)
Feb-05-26 07:01AM	Talen Energy to Report Full Year and Fourth Quarter 2025 Financial Results on February 26, 2026 (GlobeNewswire)
Feb-04-26 05:25PM	Fluence Energy, Inc. (FLNC) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -7.14%
11:42AM	Loading…
Jan-26-26 11:42AM	Scotiabank Modestly Bullish on Talen Energy (TLN) Amid Attractive Valuation Following Three Gas-Fired Power Plants Acquisition (Insider Monkey)
Jan-25-26 08:02AM	DraftKings, Abbott, And Applovin Are Among Top 10 Large Cap Losers Last Week (Jan. 19-Jan. 23): Are the Others in Your Portfolio? (Benzinga)
Jan-21-26 08:39AM	Baidu and BellRing Brands have been highlighted as Zacks Bull and Bear of the Day (Zacks)
Jan-20-26 11:04AM	Bloom Energy Outpaces Industry a Month: How to Play the Stock? (Zacks)
Jan-19-26 10:09PM	Talen Energy (TLN) Buys Three Gas-Fired Power Plants (Insider Monkey)
Jan-18-26 09:31AM	Consumer Tech News (Jan 12-16): Trump Imposes 25% Tariff on Nvidia, Eyes Starlink, Pushes $1.5T Military Budget & More (Benzinga)
Jan-16-26 04:38PM	Stocks Finish Slightly Lower as Bond Yields Climb (Barchart) -11.31%
04:28PM	Trump To Propose Tech Giants Fund Power Grid Buildouts, Energy Stocks Swing (Investor's Business Daily)
01:15PM	Russell 2000 Extends Record Run, Electricity Stocks Swing: What's Moving Markets Friday? (Benzinga)
11:53AM	Talen Energys Timing Couldnt Have Been Any Worse (24/7 Wall St.)
11:50AM	Loading…
11:50AM	These stocks have the most to lose from Trump's push to lower electricity prices (MarketWatch)
09:54AM	Stocks Climb on Renewed Optimism for AI Spending (Barchart)
09:35AM	GE Vernova shares rise as Trump, governors push for PJM power auction (Investing.com)
06:16AM	Talen Energy Corporation (TLN) Soars 11.8%: Is Further Upside Left in the Stock? (Zacks)
03:48AM	Talen in deal to buy 2.6 GW of gas plants in PJM for $3.5B (Utility Dive)
Jan-15-26 05:12PM	Amazons Big Bet: How Nuclear Power and Copper Investments Can Drive the Stock (Barrons.com) +11.80%
04:33PM	Stocks Boosted by Chip Demand Optimism (Barchart)
04:31PM	Stock Market Today: Gains Fade For Indexes, Small Caps Lead; These Breakouts Cool (Live Coverage) (Investor's Business Daily)
04:24PM	Amazon Is Channeling Henry Ford in Drive for Data-Center Dominance (Barrons.com)
03:23PM	Stock Market Today: Small Caps Lead, Some Medical Stocks Fall; BlackRock, Talen Build Bases (Live Coverage) (Investor's Business Daily)
11:14AM	Oil cools on Iran de-escalations, Talen's $3.45B gas acquisitions (Yahoo Finance Video)
10:17AM	Why Is Talen Energy Stock Gaining Thursday? (Benzinga)
10:16AM	Talen Energy Stock Jumps on $3.5 Billion Deal to 'Enhance' Data-Center Offerings (Barrons.com)
08:35AM	Another Nuclear Play Leans Into Grid Consolidation With $3.45 Billion Natural Gas Deal (Investor's Business Daily)
07:00AM	Talen Energy Continues Portfolio Expansion with Acquisition of Additional High-Quality PJM Natural Gas Assets from Energy Capital Partners (GlobeNewswire)
10:57AM	Loading…
Jan-14-26 10:57AM	Jim Cramer on Talen Energy: "I Actually Would Be Inclined to Buy Some Here" (Insider Monkey)
Jan-09-26 07:53PM	Lightning Round: Buy some Talen Energy here, says Jim Cramer (CNBC TV)
Jan-07-26 07:34AM	GE Vernova Stock Rises 13.2% in Three Months: Should You Invest Now? (Zacks)
Dec-30-25 08:30AM	Goldman Helps Lead Financing for 5-Gigawatt Texas AI Power Sites (Bloomberg)
Dec-23-25 12:29AM	Here is Why Talen Energy (TLN) Gained This Week (Insider Monkey)
Dec-22-25 09:43AM	The Zacks Analyst Blog Highlights Constellation Energy, Talen Energy and Dominion Energy (Zacks)
Dec-19-25 08:21AM	3 Nuclear Power Stocks Set to Flourish in 2026 on AI Data Center Boom (Zacks)
Dec-17-25 05:43PM	Electricity Auction Highlights Soaring Prices, Reliability Worries (Barrons.com) -6.58% +5.61%
05:05PM	Talen Energy Reports PJM Auction Results for the 2027/2028 Planning Year (GlobeNewswire)
11:59AM	BE Stock Outpaces Its Industry in the Past 3 Months: How to Play? (Zacks)
Dec-16-25 06:30AM	Biggest US Power Auction Set to Deepen Affordability Concerns (Bloomberg) +5.26%
Dec-15-25 07:00AM	Talen Energy Announces Strategic Realignment of Executive Management (GlobeNewswire)
Dec-05-25 01:28PM	Talen Energy (TLN) Falls Following a Decline in Utilities (Insider Monkey)
Dec-04-25 08:27AM	Talen Energy Corporation (TLN): A Bull Case Theory (Insider Monkey)
Dec-02-25 03:26PM	Microreactor startup Antares raises $96M for land, sea, and space-based nuclear power (TechCrunch)
Dec-01-25 11:55PM	Talen Energy (TLN) Gains Following Successful Acquisitions (Insider Monkey)
Nov-25-25 04:05PM	Talen Energy Completes Freedom and Guernsey Acquisitions (GlobeNewswire)
Nov-24-25 08:09AM	Here's What Boosted Talen Energy Corporation (TLN) in Q3 (Insider Monkey)
Nov-21-25 10:53AM	BE Stock Outperforms Its Industry in the Past Six Months: How to Play? (Zacks)
Nov-19-25 04:10PM	This $1 Billion Trump Loan For Three Mile Island Lifts S&P 500 Nuclear Giant (Investor's Business Daily) -5.48%
Nov-18-25 08:00AM	Talen Energy Receives Regulatory Clearance for Freedom and Guernsey Acquisitions (GlobeNewswire)
Nov-14-25 07:36AM	Talen Energy Corporation (TLN) Management Reiterated Its Full-Year Guidance (Insider Monkey)
Nov-13-25 01:00AM	AI Data Centers Need More Power Right Now. These Companies Can Deliver It. (Barrons.com)
Nov-07-25 04:00PM	S&P 500 Nuclear Leader Misses On Earnings. The Stock Reversed Higher. (Investor's Business Daily)
Nov-06-25 12:00AM	Talen Energy Corp (TLN) Q3 2025 Earnings Call Highlights: Strong Liquidity and Strategic ... (GuruFocus.com)
Nov-05-25 07:50PM	Talen Energy Corporation (TLN) Q3 Earnings Lag Estimates (Zacks)
06:45PM	Talen Energy: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Talen Energy Reports Third Quarter 2025 Results, Narrows 2025 Guidance (GlobeNewswire)
Nov-04-25 07:22AM	Talen Energy Corp (TLN) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Nov-03-25 05:35PM	Ameresco (AMRC) Tops Q3 Earnings and Revenue Estimates (Zacks)
10:00AM	Will Energy Vault Holdings, Inc. (NRGV) Report Negative Earnings Next Week? What You Should Know (Zacks)
Oct-30-25 09:30AM	Talen Energy, Eos Energy Partner for GWh-Scale Energy Storage in Pennsylvania to Support AI Growth (Insider Monkey)
Oct-29-25 09:40PM	Microsoft earnings offer a bullish read for power stocks (MarketWatch)
11:31AM	CEG vs. TLN: Which Power-Producer Stock Has the Stronger Outlook? (Zacks)
10:00AM	Talen Energy Corporation (TLN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-27-25 04:05PM	Talen Energy Announces Closing of $2.69 Billion Senior Notes Offerings (GlobeNewswire)
Oct-24-25 11:47AM	Trump Administration Moves to Accelerate AI Power Hookups (Bloomberg) +6.25%
Oct-22-25 08:11PM	Talen Energy Corporation (TLN): A Bull Case Theory (Insider Monkey)
08:20AM	Eos Energy to spend $353M to establish factory, relocate HQ to Pittsburgh area (Manufacturing Dive)
Oct-21-25 05:03PM	Eos Energy CEO discusses battery maker's Pennsylvania investment (Yahoo Finance Video) -6.08%
Oct-16-25 01:11PM	TLN Stock's Strategic Acquisitions to Boost Long-Term Prospects (Zacks)
08:45AM	GEV Stock Underperforms Industry in a Month: What Should Investors Do? (Zacks)
Oct-15-25 01:11PM	This low-risk sector has outperformed tech stocks this year - but it's still all about AI (MarketWatch)
01:00PM	TLN Stock Trades Above 50 & 200-Day SMAs: How to Play It Now? (Zacks)
Oct-14-25 07:00AM	Talen Energy to Report Third Quarter 2025 Financial Results on November 5, 2025 (GlobeNewswire)
Oct-10-25 04:05PM	Talen Energy Announces Pricing of Senior Notes Offerings (GlobeNewswire) -7.12% +5.57%
01:48PM	Want a Stock Market Boost? Mention AI on Your Conference Call. (Barrons.com)
Oct-09-25 07:36AM	Talen Energy Announces Launch of Proposed Senior Notes Offerings (GlobeNewswire)
Oct-07-25 04:52AM	Talen Energy secures $1.2bn in financing for two power plant acquisitions (Power Technology)
Oct-06-25 07:41AM	Talen Energy Announces Launch of $1.2 Billion Term Loan B Financing, $200 Million Upsize of Revolving Credit Facility and $200 Million Upsize of Stand-Alone Letter of Credit Facility (GlobeNewswire)
Sep-27-25 12:58AM	Scotiabank Initiates Coverage of Talen Energy Corporation (TLN) With a Sector Perform Rating (Insider Monkey)
Sep-24-25 04:00AM	Big Tech's AI ambitions are straining the US power grid. Natural gas might be its answer. (Yahoo Finance)
Sep-23-25 11:53AM	The Zacks Analyst Blog Highlights MasTec, Comfort Systems USA and Talen Energy (Zacks)
Sep-22-25 08:08AM	3 Must-Buy Non-Tech Stocks for the Long Term Amid AI Data Center Boom (Zacks)
Sep-17-25 02:30PM	Analysts Say Talen Energy (TLN) Guidance Is 'Clearly Conservative' (Insider Monkey)
04:44AM	Zacks Investment Ideas feature highlights: Talen, Amazon, Nvidia, Constellation Energy and MasTec (Zacks)
Sep-16-25 03:45PM	3 Top AI Energy Stocks to Buy and Hold Forever (Zacks)
02:15PM	Talen Energy Corporation (TLN): A Bull Case Theory (Insider Monkey)
10:03AM	GEV Stock Wins Deal to Repower German Wind Farm: Should You Invest Now? (Zacks)
Sep-05-25 04:12PM	What AI Bubble? Vistra Makes A Powerful Run As AI Data Centers Fuel Nuclear Growth. (Investor's Business Daily)
Sep-04-25 11:43AM	Bloom Energy Outpaces Industry in a Year: How to Play the Stock? (Zacks)
Sep-03-25 08:45AM	Here's What Boosted Talen Energy Corporation's (TLN) Performance in Q2 (Insider Monkey)
Aug-27-25 12:00PM	Talen Energy Corporation (TLN) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
05:42AM	Nvidia Has the Power to Move Markets Watch These Sectors. (Barrons.com)
01:01AM	BofA Maintains Buy on Talen Energy (TLN) Following Mark-to-Market Power Price Adjustments (Insider Monkey)
Aug-26-25 01:36PM	The S&P 500 Will Get a Bit More Digital When the Index Makes Its Next Change Thursday (Investopedia) +6.54%
12:06PM	This Stock Is Replacing Walgreens in the S&P 500 (Barrons.com)
11:18AM	These Stocks Are Moving the Most Today: EchoStar, AT&T, AMD, Lilly, Boeing, DJT, Talen, Semtech, and More (Barrons.com)
09:40AM	Has Tidewater (TDW) Outpaced Other Oils-Energy Stocks This Year? (Zacks)
08:02AM	Interactive Brokers To Join S&P 500; Robinhood, AppLovin Snubbed Again (Investor's Business Daily)

Talen Energy Corp. engages in the operation of power infrastructure. It produces and sells electricity, capacity, and ancillary services into wholesale power markets through its subsidiaries. The company was founded on July 2, 2014 and is headquartered in Houston, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Rubric Capital Management LP	10% Owner	Jun 27 '25	Sale	296.04	178,000	52,695,684	5,734,970	Jun 27 06:45 PM
Rubric Capital Management LP	10% Owner	Jun 25 '25	Sale	291.29	108,313	31,550,492	6,015,187	Jun 27 06:45 PM
Rubric Capital Management LP	10% Owner	Jun 26 '25	Sale	291.98	102,217	29,845,813	5,912,970	Jun 27 06:45 PM
Horton Anthony R	Director	Mar 06 '25	Buy	190.59	1,000	190,588	1,000	Mar 10 04:08 PM

HRTX

Heron Therapeutics Inc

TLN

Talen Energy Corp

Upgrade your FINVIZ experience